30 May 2023
Armis Biopharma® Announces 510(k) Clearance for VeriCyn® Wound Wash

Armis Biopharma® Announces 510(k) Clearance for VeriCyn® Wound Wash FORT COLLINS, CO (May 31, 2023) – Armis Biopharma, Inc. announced today the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance for the VeriCyn® Wound Wash medical device. VeriCyn® Wound Wash provides skin-friendly wound care with a unique formula that is chlorine and surfactant […]

Read More
14 Dec 2022
Veriox® DECON is Shown to Kill Biological Warfare Agent, Anthrax

 FOR IMMEDIATE RELEASE  DECEMBER 14, 2022    Veriox® DECON is Shown to Kill Biological Warfare Agent, Anthrax    December 14, 2022 (Ft. Collins, CO) – Armis Biopharma® Inc., announced today that the product, Veriox® DECON was successful in destroying the Sterne strain of anthrax spores on canine skin. A poster describing this efficacy was displayed […]

Read More